MedTrace Logo

Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease

NCT00217880 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-08-19

No results posted yet for this study

Summary

The purpose of this study is to identify biological markers of disease in patients with acute lung injury (ALI) that are predictive of either disease susceptibility or prognosis, or that identify novel targets of therapeutic intervention.

Conditions

  • Respiratory Distress Syndrome, Adult

Interventions

PROCEDURE

Bronchoscopy

A bronchoscopy test will occur to view the participant's airways.

Sponsors & Collaborators

Principal Investigators

  • Theodore J. Standiford, MD · University of Michigan

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2009-04-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00217880 on ClinicalTrials.gov